Investing.com -- Jefferies initiated coverage of Medline Inc. (NASDAQ:MDLN) with a “buy” rating in a note dated Monday, citing the company’s combined supply chain and private-label product model and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results